Genetic testing referral and germline pathogenic variants in patients with breast cancer and another non-breast cancer
Rachel Hodan(Cancer Institute (WIA)), Allison W. Kurian(Stanford University), Shilpa Narayan(Stanford Health Care), Summer S. Han(Stanford Health Care), Victor Ritter, Mina Satoyoshi(Stanford Medicine)
Cited by 1
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660
Genetic/Familial High-Risk Assessment: Breast and Ovarian
|Journal of the National Comprehensive Cancer Network|2010|650